Related Experiment Video
Updated: Jun 16, 2026
10:25
Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
Published on: September 20, 2019
Knocking down Cav1 calcium channels implicated in Th2 cell activation prevents experimental asthma
Marilena Djata Cabral1, Pierre-Emmanuel Paulet, Virginie Robert
1INSERM U563, Centre de Physiopathologie de Toulouse Purpan, Place du Dr Baylac, Toulouse Cedex 3, France.
American Journal of Respiratory and Critical Care Medicine
|February 20, 2010
Summary
Targeting voltage-dependent calcium (Ca(v)1) channels in Th2 cells offers a novel strategy for treating allergic asthma. Inhibiting these channels in T lymphocytes effectively reduced airway inflammation and hyperreactivity in experimental asthma models.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Th2 cells and their associated cytokines (IL-4, IL-5, IL-13) are central to allergic asthma pathogenesis.
- Identifying key signaling molecules in Th2 cells is crucial for developing targeted asthma therapies.
- Previous research indicated that dihydropyridines modulate Th2 cell functions.
Purpose of the Study:
- To investigate the selective expression and function of voltage-dependent calcium (Ca(v)1) channels in Th2 cells.
- To determine if inhibiting Ca(v)1 channels could prevent or treat experimental asthma.
Main Methods:
- Real-time PCR and Western blotting were used to detect Ca(v)1 channel expression in Th2 and Th1 cells.
- Ca(v)1 antisense oligodeoxynucleotides (Ca(v)1AS) were used to inhibit Ca(v)1 channels in Th2 cells.
- The effects of Ca(v)1AS on calcium signaling, cytokine production, and asthma models (passive and active) were evaluated.
Main Results:
- Mouse Th2 cells selectively expressed Ca(v)1.2 and Ca(v)1.3 channels, unlike Th1 cells.
- Ca(v)1AS treatment impaired Ca(2+) signaling and cytokine production in Th2 cells.
- Intranasal Ca(v)1AS administration suppressed airway inflammation and hyperreactivity in experimental asthma models.
Conclusions:
- Th2 cells uniquely express functional Ca(v)1 channels.
- Targeting Ca(v)1 channels in T lymphocytes represents a promising therapeutic strategy for allergic asthma.
- This approach may offer a novel way to prevent or treat asthma by modulating T cell function.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...